Trials / Unknown
UnknownNCT02992496
Investigation of Antidepressant Efficacy of Oral Ketamine Treatment
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this double-blind, controlled, randomized study is to investigate the antidepressant efficacy of oral ketamine treatment in patients suffering from a major depressive episode.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | 1mg/kg, 6 applications over 2 weeks |
| DRUG | Midazolam Hydrochloride | 0.03mg/kg, 6 applications over 2 weeks |
Timeline
- Start date
- 2017-04-24
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2016-12-14
- Last updated
- 2019-09-03
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02992496. Inclusion in this directory is not an endorsement.